{
  "docId": "019de070-d3cd-70da-8da9-11fac56c0e6a",
  "docSlug": "a10c554cbe4a4cf1ea91fc4610f64010",
  "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 27 slides",
  "authorId": "neurobo-pharmaceuticals",
  "authorName": "NeuroBo Pharmaceuticals",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 16,
  "pageCount": 27,
  "prevPage": 15,
  "nextPage": 17,
  "slideType": "appendix_methodology",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The slide outlines a randomized controlled trial structure with specific timelines and patient criteria.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-d3cd-70da-8da9-11fac56c0e6a/16",
  "deckHref": "/decks/019de070-d3cd-70da-8da9-11fac56c0e6a",
  "deckJsonHref": "/decks/019de070-d3cd-70da-8da9-11fac56c0e6a.json",
  "deckAnchorHref": "/decks/019de070-d3cd-70da-8da9-11fac56c0e6a#slide-16",
  "components": [
    {
      "bbox": {
        "h": 0.3,
        "w": 0.9,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "diagram",
      "text": "Screening, Randomization, Treatment Arms, Follow-up, Phase 3 transition",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d10b703c-9975-4629-ba30-909c5c42322c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.2,
        "x": 0.05,
        "y": 0.65
      },
      "kind": "list",
      "text": "Criteria: Age >18, Moderate/Severe COVID-19, Confirmed by RT-PCR, Not on a ventilator",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "359b4440-2ca0-4a8b-befa-ae36678551eb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.15,
        "x": 0.75,
        "y": 0.65
      },
      "kind": "paragraph",
      "text": "Outcomes: Continue to Phase 3 to test efficacy",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "494e18b2-fdac-4934-83a7-2ac6339b5572",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.15,
        "x": 0.55,
        "y": 0.65
      },
      "kind": "paragraph",
      "text": "Primary Endpoint: Safety and adverse events",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5cd1c54b-2055-4c51-a504-5c4018b69024",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.2,
        "x": 0.3,
        "y": 0.65
      },
      "kind": "paragraph",
      "text": "Primary Objective: Evaluate effect of dosing regimen on clinical outcomes after niclosamide therapy with 60 patients",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f5f12007-33a0-4d55-b0db-7394ea91e0e7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.45,
        "x": 0.05,
        "y": 0.03
      },
      "kind": "title",
      "text": "Clinical Trial Design: Phase 2/3",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f4b952ad-f492-4cb3-b1db-bba6f8691c7a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Process flow",
      "slug": "process-flow",
      "agent": null,
      "layer": "slide",
      "matchId": "76f63832-dba4-487d-9d50-55d971ee33cf",
      "evidence": "diagram/process: Screening, Randomization, Treatment Arms, Follow-up, Phase 3 transition",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "d7ece76b-0995-4550-8e85-469133702a8a",
      "evidence": "Flow diagram of clinical trial stages",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}